Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.100
-0.080 (-6.78%)
Mar 31, 2025, 2:32 PM EDT - Market open
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $5.97 million as of March 31, 2025. Its market cap has increased by 121.00% in one year.
Market Cap
5.97M
Enterprise Value
3.25M
1-Year Change
121.00%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $5.97M, a decrease of -89.61%. That is a compound annual growth rate of -46.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 6.41M | 132.60% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.29B |
| UnitedHealth Group | 479.76B |
| Johnson & Johnson | 399.36B |
| AbbVie | 369.61B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.51B |
| Merck & Co. | 225.61B |
| AstraZeneca | 225.46B |